BioCentury

8:00 AM GMT, Mar 22, 2004
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Emerging Company Profile

Algodign: From Russia with data

When he co-founded Protein Design Labs Inc., Cary Queen brought to the company the idea of using computer modeling to improve proteins - antibodies in the case of PDLI. Now, as chairman of Algodign Inc., he's expanding the idea to small molecules. Although not the first company to use computer-based drug design, Algodign believes its software offers advantages compared to competing

Read the full 614 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.